Ceftaroline is a novel broad-spectrum cephalosporin that has activity against gram-negative and gram-positive bacteria including methicillin-resistant Staphylococcus aureus. It was approved by the Food and Drug Administration for the treatment of community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections in October 2010. We report 2 cases of S aureus vertebral osteomyelitis treated effectively with ceftaroline.
From the Division of Infectious Disease, Henry Ford Hospital, Detroit, MI.
Correspondence to: Hadeel Zainah, MD, Henry Ford Hospital, 2799 W Grand Blvd, CFP 304, Detroit, MI, 48202. E-mail: firstname.lastname@example.org.
Disclosure: Hadeel Zainah and Marwa Hammoud have no funding or conflicts of interest to disclose. Jose A. Vazquez is in the speakers’ bureaus of Pfizer, Astellas, Merck, and Forest.
Hammoud and Zainah contributed equally to the manuscript.